NAD Refers Advertising for Pursuit of Research’s ‘NutriiVeda’ to FTC Following Second Compliance Review
New York, NY – June 10, 2015 – The National Advertising Division has referred advertising claims made by Pursuit of Research for its NutriiVeda whey powder dietary supplement to the Federal Trade Commission for further review. NAD’s decision comes after the company failed to comply with the terms of a previous NAD decision.
NAD is an investigative unit of the advertising industry’s system of self-regulation. It is administered by the Council of Better Business Bureaus.
The claims made by Pursuit of Research were initially challenged before NAD by NourishLife, LLC, a competing maker of dietary supplements.
In the underlying decision, NAD determined that the evidence submitted by the advertiser was insufficient to support its claims that NutriiVeda cured or treated the symptoms of apraxia, autism and epilepsy in children or could improve their speech, language acquisition, fine and gross motor skills, awareness of surrounding, facial expressions multi-tasking, behavioral and developmental delays, seizures and sensory perception or any other symptoms of neurological disorders. These claims appeared on two of the advertiser’s websites. NAD further determined that the testimonials on the advertiser’s websites conveyed the same unsupported messages that NutriiVeda treated or cured symptoms of their diseases, such as difficulty with speech.
Based on its review of the advertiser’s evidence, NAD recommended that the advertiser discontinue its health and performance claims, including those found in testimonials. The advertiser agreed to comply with NAD’s recommendations.
NAD opened a compliance inquiry, but was assured by the advertiser the claims would be modified or discontinued. In May, NAD learned that the advertiser continued to disseminate the unsupported claims and testimonials and opened a second compliance review.
In its decision, NAD said that it was “extremely concerned that the advertiser continues to make these unsupported claims of near miraculous recovery from apraxia, autism, epilepsy and other neurological disorders, despite its representations on two occasions that it would discontinue them. Parents of children that suffer from these diseases are a vulnerable target population.”
As a result, NAD has referred the advertising at issue to the FTC for further review.
Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.
Latest Decisions
Direct Selling Self-Regulatory Council Recommends Valentus Discontinue Earnings and Product Performance Claims
McLean, VA – December 23, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) recommended Valentus, a direct selling company that sells nutritional and lifestyle products, discontinue earnings and health-related product performance claims made on social media and on the Valentus website.
Direct Selling Self-Regulatory Council Refers Olive Tree Earnings Claims to the FTC and California AG for Possible Enforcement Action
McLean, VA – December 20, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) referred Olive Tree to the Federal Trade Commission (FTC) and California Attorney General's Office for possible enforcement action after Olive Tree failed to respond to a DSSRC inquiry into earnings claims.
Children’s Advertising Review Unit Recommends JustPlay Discontinue or Modify Daisy the Yoga Goat Claims
New York, NY – December 19, 2024 - The Children’s Advertising Review Unit (CARU) launched an investigation into advertising for Just Play’s furReal Daisy the Yoga Goat seeking to determine if the toy’s product packaging and commercial advertisements comply with CARU’s Self-Regulatory Guidelines for Children’s Advertising.
In National Advertising Division Fast-Track SWIFT Challenge, Oral Essentials Voluntarily Modifies “Made in USA” Claims
New York, NY – December 19, 2024 – In a National Advertising Division challenge, Oral Essentials agreed to permanently modify its claim that certain Oral Essentials oral healthcare products are “Made in USA.”